Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME
- PMID: 9843903
- DOI: 10.1152/ajprenal.1998.275.6.F870
Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME
Abstract
Experimental evidence indicates that the renal circulation is more sensitive to the effects of nitric oxide (NO) synthesis inhibition than other vascular beds. To explore whether in men the NO-mediated vasodilator tone is greater in the renal than in the systemic circulation, the effects of three different intravenous infusions of NG-nitro-L-arginine methyl ester (L-NAME; 1, 5, and 25 microg. kg-1. min-1 for 30 min) or placebo on mean arterial pressure (MAP), systemic vascular resistance (SVR), renal blood flow (RBF), renal vascular resistance (RVR), glomerular filtration rate (GFR), and fractional sodium and lithium excretion (FENa and FELi) were studied in 12 healthy subjects, each receiving randomly two of the four treatments on two different occasions. MAP was measured continuously by means of the Finapres device, and stroke volume was calculated by a model flow method. GFR and RBF were estimated from the clearances of radiolabeled thalamate and hippuran. Systemic and renal hemodynamics were followed for 2 h after start of infusions. During placebo, renal and systemic hemodynamics and FENa and FELi remained stable. With the low and intermediate L-NAME doses, maximal increments in SVR and RVR were similar: 20.4 +/- 19.6 and 23.5 +/- 16.0%, respectively, with the low dose and 31.4 +/- 26.7 and 31.2 +/- 14.4%, respectively, with the intermediate dose (means +/- SD). With the high L-NAME dose, the increment in RVR was greater than the increment in SVR. Despite a decrease in RBF, FENa and FELi did not change with the low L-NAME dose, but they decreased by 31.2 +/- 11.0 and 20.2 +/- 6.3%, respectively, with the intermediate dose and by 70.8 +/- 8.1 and 31.5 +/- 15.9% with the high L-NAME dose, respectively. It is concluded that in men the renal circulation is not more sensitive to the effects of NO synthesis inhibition than the systemic circulation and that the threshold for NO synthesis inhibition to produce antinatriuresis is higher than the threshold level to cause renal vasoconstriction.
Similar articles
-
Role of angiotensin II in L-NAME-induced systemic and renal hemodynamic effects in hydrochlorothiazide-pretreated hypertensive subjects.J Hypertens. 2003 Feb;21(2):345-51. doi: 10.1097/00004872-200302000-00026. J Hypertens. 2003. PMID: 12569265 Clinical Trial.
-
Dopamine-2 receptor blockade potentiates the renal effects of nitric oxide inhibition in humans.Hypertension. 1998 Jan;31(1 Pt 2):277-82. doi: 10.1161/01.hyp.31.1.277. Hypertension. 1998. PMID: 9453316
-
Calcium channel blockade blunts the renal effects of acute nitric oxide synthase inhibition in healthy humans.Am J Physiol Renal Physiol. 2017 May 1;312(5):F870-F878. doi: 10.1152/ajprenal.00568.2016. Epub 2017 Feb 8. Am J Physiol Renal Physiol. 2017. PMID: 28179255 Clinical Trial.
-
Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.Am J Physiol. 1996 May;270(5 Pt 2):F845-51. doi: 10.1152/ajprenal.1996.270.5.F845. Am J Physiol. 1996. PMID: 8928847 Clinical Trial.
-
Systemic changes in the elderly patient and their anaesthetic implications.Can Anaesth Soc J. 1985 Mar;32(2):184-7. doi: 10.1007/BF03010048. Can Anaesth Soc J. 1985. PMID: 2859102 Review. No abstract available.
Cited by
-
Evaluation of bioavailability of nitric oxide in coronary circulation by direct measurement of plasma nitric oxide concentration.Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11456-61. doi: 10.1073/pnas.0501392102. Epub 2005 Jul 28. Proc Natl Acad Sci U S A. 2005. PMID: 16051703 Free PMC article.
-
Plasma detection of NO by a catheter.Med Biol Eng Comput. 2008 May;46(5):509-16. doi: 10.1007/s11517-008-0333-z. Med Biol Eng Comput. 2008. PMID: 18347830
-
Central and peripheral haemodynamic effects of L-NAME infusion in healthy volunteers.Eur J Clin Pharmacol. 2003 Jul;59(3):195-9. doi: 10.1007/s00228-003-0601-7. Epub 2003 May 17. Eur J Clin Pharmacol. 2003. PMID: 12756513 Clinical Trial.
-
Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease.High Blood Press Cardiovasc Prev. 2014 Jun;21(2):89-105. doi: 10.1007/s40292-014-0056-1. Epub 2014 May 1. High Blood Press Cardiovasc Prev. 2014. PMID: 24789091 Review.
-
Mechanisms of acute natriuresis in normal humans on low sodium diet.J Physiol. 2003 Jan 15;546(Pt 2):591-603. doi: 10.1113/jphysiol.2002.027425. J Physiol. 2003. PMID: 12527745 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous